Kevin Kunzmann

New results from a pair of phase 3 trials will be used to support AbbVie's anticipated NDA submission in 2019.

In using the EDSS and 9HPT scales as a metric for the therapy’s influence on disability risk reduction, the investigators were additionally providing context to ocrelizumab’s benefits for ambulation rates and MS-related costs.

About 21% to 74% of patients with AF will also have obstructive sleep apnea. What is one medical center doing to find these patients in their cardiology department?

A popularizing procedure among stroke centers was the basis of clinical research for the medical center, and is now improving in practice.

How surgeons' duties surround the entire invasive process, and therefore make them something closer to specialists.

A meta-analysis of more than 7 million patients confirms that just 1 instance of a concussion or mild TBI is associated with a two-fold greater risk of suicide.

Investigators praised the excellent effectiveness of both therapies, but advised care regarding the increased odds of adverse events requiring hospitalizations.

Investigators have found a pair of increased biomarker levels indicate patients with AF are at a greater risk of neurodegeneration.

Recent clinical assessment of gastroesophageal reflux disease has linked it to an inflammatory response triggered by cytokines.

Who is the best candidate for invasive treatment in the GERD population?

How increasing obesity rates have affected the prevalence of GERD and re-prioritized first-line care.

With the FDA approval, Abbot now anticipates to offer new assays for use this fall.

The PicoAMH Elisa test, which measures the amount of Anti-Müllerian Hormone in the blood, was supported by data assessing 690 women.

The single-dose, oral therapy becomes the first new influenza antiviral with a novel mechanism of action approved by the FDA in nearly 20 years.

The vaccine is designed to help protect patients against a pair of both influenza A strain and B strain viruses. It is currently available in the US for the 2018-19 flu season.

The new Medtronic device is capable of repairing thoracic aortic aneurysms, blunt thoracic aortic injuries, penetrating atherosclerotic ulcers, intramural hematomas, and aortic type B dissections.

The most reliable practice for helping a patient quit is comprehensive, and catered to their medical, physical, and financial goals.

Coverage of the post-surgery pain management therapy's strength has overlooked its clinical setting use and potential need.

The interleukin pathway-targeting monoclonal antibody has been previously approved for adult atopic dermatitis, and is being considered for a handful more inflammatory or allergic conditions.

Though new therapies are still in the distant future, advances in diagnosis may be on the horizon.

The IL-4 and -13 inhibitor antibody also reported improved outcomes in patients with comorbid asthma.

Distinguishing pulmonary arterial hypertension in patients is a difficult early diagnosis. But seeking out a combination of unexplained symptoms is a good first step.

Experts advise that primary care physicians give pause next time they treat a patient with unexplained dyspnea—could it be pulmonary hypertension?

Though the commonly accepted ratio is 3:1 women, longtime clinicians suggest PAH ratio is more likely closer to 4:1.

The 2019 CHEST Meeting in New Orleans may be headlined by newly approved therapies including dupilumab and tezepelumab.

Using data registries from initial trials, companies such as Actelion will be looking to expand research beyond the first first or second year of care in patients with PAH.

Recent trials have evidenced that minority patient groups in particular are more likely to worsen their primary treatment adherence while embracing alternative medicine measures.

Once physicians know if it's the cause of PAH or just simply an overlap, comorbidities have to be closely monitored as disease progression.

A twice-daily 50 mcg dose of the nebulized LAMA therapy also had better results for patients with poor FEV1 compared to tiotropium.

Why delving into the symptoms of the most at-need patients is critical for care.